Healthcare & Medical Devices Global On demand · 24-48h

Global Medical Imaging Probe Market Strategic Research Report

Global Medical Imaging Probe Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medical Imaging Probe Market
$4.32B2025
6.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Ultrasound Probe, Endoscopic Imaging Probe, Optical Imaging Probe

By Application: Hospitals and Medical Institutions, Independent Imaging Centers, Medical Research Institutions, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: GE HealthCare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, Fujifilm Healthcare, Samsung Medison, Esaote, Butterfly Network, Clarius Mobile Health, Alpinion Medical Systems, Mindray Bio-Medical Electronics, SonoScape Medical, SIUI, Wisonic Medical Technology, Chison Medical Technologies, EDAN Instruments, Anke High-Tech, Wuhan DM Medical Technology, Kaixin Electronic Equipment

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 137 pages
Market size 2025
$4.32B
Billion USD
Forecast CAGR
6.6%
2025-2032
Forecast 2032
$6.8B
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Medical Imaging Probe market size is predicted to grow from US$ 4,322 million in 2025 to US$ 6,802 million in 2032; it is expected to grow at a CAGR of 6.6% from 2026 to 2032.

In 2025, global Medical Imaging Probe production reached approximately 1.2 million units, with an average global market price of around USD 3,500 per unit.

The gross profit margin of major companies in the industry is between 45%–60%.

In 2025, the global production capacity of Medical Imaging Probe was approximately 1.6 million units.

Medical Imaging Probe refers to specialized medical imaging components used to capture biological signals and generate diagnostic images of human tissues and organs. These probes convert physical signals such as ultrasound waves or electromagnetic signals into digital imaging data through transducer elements, sensors, and signal processing components. They are widely used in ultrasound imaging, endoscopic imaging, cardiac imaging, and other clinical diagnostic applications. The product scope includes ultrasound probes, endoscopic imaging probes, and other diagnostic imaging probes, excluding complete medical imaging systems.

The industry chain of Medical Imaging Probe includes upstream materials and components, midstream probe manufacturing, and downstream medical applications. Upstream suppliers provide piezoelectric materials, semiconductor components, optical elements, cables, connectors, and precision structural parts. Midstream manufacturers conduct probe design, component assembly, calibration, signal testing, and quality verification. Downstream applications include hospitals, diagnostic centers, medical imaging institutions, and clinical departments requiring high-precision imaging solutions.

This report presents a comprehensive overview of the global Medical Imaging Probe market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Ultrasound Probe
  • Endoscopic Imaging Probe
  • Optical Imaging Probe

Segment by Probe Structure

  • Convex Probe
  • Linear Probe
  • Phased Array Probe

Segment by Frequency Range

  • Low Frequency Probe (<5 MHz)
  • Medium Frequency Probe (5–10 MHz)
  • High Frequency Probe (>10 MHz)

Segment by Application

  • Hospitals and Medical Institutions
  • Independent Imaging Centers
  • Medical Research Institutions
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Imaging Probe market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals and Medical Institutions, Independent Imaging Centers, Medical Research Institutions evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medical Imaging Probe Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$4.32B
2025
Forecast
$6.8B
2032
CAGR
6.6%
2025–2032
Regiones
5
global
Key companies
GE HealthCarePhilips HealthcareSiemens HealthineersCanon Medical SystemsFujifilm HealthcareSamsung MedisonEsaoteButterfly Network
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Ultrasound ProbeEndoscopic Imaging ProbeOptical Imaging Probe
By Application
Hospitals and Medical InstitutionsIndependent Imaging CentersMedical Research InstitutionsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Ultrasound Probe
  • 3.1.3 Endoscopic Imaging Probe
  • 3.1.4 Optical Imaging Probe
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals and Medical Institutions
  • 4.1.3 Independent Imaging Centers
  • 4.1.4 Medical Research Institutions
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 GE HealthCare
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Philips Healthcare
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Siemens Healthineers
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Canon Medical Systems
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Fujifilm Healthcare
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Samsung Medison
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Esaote
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Butterfly Network
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Clarius Mobile Health
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Alpinion Medical Systems
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Mindray Bio-Medical Electronics
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 SonoScape Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 SIUI
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Wisonic Medical Technology
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Chison Medical Technologies
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 EDAN Instruments
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Anke High-Tech
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Wuhan DM Medical Technology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Kaixin Electronic Equipment
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Medical Imaging Probe market?
The global Medical Imaging Probe market is estimated at US$ 4.32 billion in 2025 (base year) and is projected to reach US$ 6.8 billion by 2032.
What is the forecast CAGR for the Medical Imaging Probe market?
The market is expected to grow at a CAGR of 6.6% from 2026 to 2032, expanding from US$ 4.32 billion in 2025 to US$ 6.8 billion in 2032, roughly 1.6 times its base-year value.
What is Medical Imaging Probe?
In 2025, global Medical Imaging Probe production reached approximately 1.2 million units, with an average global market price of around USD 3,500 per unit.
What are the main segments of the Medical Imaging Probe market by type?
By type, the market is segmented into Ultrasound Probe, Endoscopic Imaging Probe and Optical Imaging Probe.
Which applications drive demand in the Medical Imaging Probe market?
Key applications covered include Hospitals and Medical Institutions, Independent Imaging Centers, Medical Research Institutions and Other.
Who are the key players in the Medical Imaging Probe market?
Key players profiled include GE HealthCare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, Fujifilm Healthcare, Samsung Medison, Esaote and Butterfly Network, among 19 companies covered in total.
Which regions and countries are covered for Medical Imaging Probe?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Medical Imaging Probe market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals and Medical Institutions, Independent Imaging Centers and Medical Research Institutions, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medical Imaging Probe market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.